PMID: 9449711Mar 21, 1998Paper

Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans

The Journal of Experimental Medicine
A MencacciL Romani

Abstract

Interleukin (IL)-4-deficient mice were used to assess susceptibility to systemic or gastrointestinal Candida albicans infections, as well as parameters of innate and elicited T helper immunity. In the early stage of systemic infection with virulent C. albicans, an unopposed interferon (IFN)-gamma response renders IL-4-deficient mice more resistant than wild-type mice to infection. Yet, IL-4-deficient mice failed to efficiently control infection in the late stage and succumbed to it. Defective IFN-gamma and IL-12 production, but not IL-12 responsiveness, was observed in IL-4-deficient mice that failed to mount protective T helper type 1 cell (Th1)-mediated acquired immunity in response to a live vaccine strain of the yeast or upon mucosal immunization in vivo. In vitro, IL-4 primed neutrophils for cytokine release, including IL-12. However, late treatment with exogenous IL-4, while improving the outcome of infection, potentiated CD4(+) Th1 responses even in the absence of neutrophils. These findings indicate that endogenous IL-4 is required for the induction of CD4(+) Th1 protective antifungal responses, possibly through the combined activity on cells of the innate and adaptive immune systems.

References

Nov 1, 1992·Infection and Immunity·L RomaniF Bistoni
Aug 1, 1987·The Journal of Experimental Medicine·L S ParkD L Urdal
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A P Perlmutter, W Gilbert
Aug 1, 1995·Current Opinion in Immunology·L Romani, D H Howard
Jun 1, 1995·European Journal of Immunology·L TonnettiL Romani
Jun 1, 1995·Trends in Microbiology·P PuccettiF Bistoni
Jan 1, 1995·The Journal of Experimental Medicine·M VajdyN Lycke
Jan 1, 1995·Clinical and Experimental Immunology·A M Mowat, M B Widmer
Jan 1, 1994·Annual Review of Immunology·R A Seder, W E Paul
Oct 1, 1994·European Journal of Immunology·T von der WeidJ Langhorne
Jun 1, 1994·The Journal of Infectious Diseases·P PuccettiF Bistoni
Aug 1, 1993·The Journal of Infectious Diseases·B J KullbergR van Furth
Sep 27, 1993·Journal of Immunological Methods·S L ReinerR M Locksley
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·D J HiltonT A Willson
Mar 1, 1996·Infection and Immunity·C W RobertsJ Alexander
Apr 1, 1996·International Immunology·E J PearceM Kopf
Mar 1, 1996·Infection·H M HasselhornF W Tiller
Dec 1, 1995·Immunological Reviews·M KopfF Brombacher
Sep 1, 1995·Research in Immunology·L RomaniP Puccetti
Jun 1, 1996·Research in Immunology·S Bahram, T Spies
Dec 1, 1996·Infection and Immunity·A MencacciL Romani
Sep 1, 1996·The Journal of Experimental Medicine·M KopfW Solbach
Mar 3, 1997·The Journal of Experimental Medicine·L RoggeF Sinigaglia

❮ Previous
Next ❯

Citations

Nov 9, 2000·European Journal of Immunology·J AlexanderF Brombacher
Aug 29, 2001·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·Z LiuJ Li
Oct 26, 2007·Archives of Dermatological Research·Kilian EyerichClaudia Traidl-Hoffmann
Aug 28, 1998·Research in Immunology·A CassoneA Torosantucci
Aug 28, 2003·Current Opinion in Microbiology·Gary B Huffnagle, George S Deepe
Jan 31, 2009·Medical Mycology·Luigina Romani
Dec 19, 2001·The Journal of Experimental Medicine·T SchülerT Blankenstein
Jun 24, 2004·The Journal of Experimental Medicine·Petr BocekWilliam E Paul
Oct 19, 2004·Clinical Microbiology Reviews·Louis de RepentignyPaul Jolicoeur
Jun 24, 2003·Infection and Immunity·Lucy A GildeaGeorge S Deepe
Oct 22, 2005·Infection and Immunity·Amariliz RiveraEric G Pamer
Nov 6, 2010·Clinical & Developmental Immunology·Robert B AshmanChristine A Wells
Jul 12, 2003·American Journal of Respiratory Cell and Molecular Biology·Rebecca Blackstock, Juneann W Murphy
Feb 5, 2009·Blood·Isabela AlcázarAna C Carrera
Feb 21, 2009·PloS One·Luciana Pereira RuasMaria-Cristina Roque-Barreira
May 16, 2007·PLoS Pathogens·Magdalena RadwanskaFrank Brombacher
Feb 24, 2001·Clinical and Experimental Immunology·D de Moraes-VasconcelosA J Duarte
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·D L RaduC A Bona
Aug 16, 2014·Journal of Immunology Research·Anabelle VisperasBooki Min
Sep 19, 2014·Medical Mycology Journal·Norihito TarumotoYoshitsugu Miyazaki
Oct 13, 2010·Annual Review of Immunology·Gordon D Brown
Apr 20, 2001·Scandinavian Journal of Immunology·D M BullensJ L Ceuppens
Aug 22, 2006·Expert Opinion on Biological Therapy·Alieke G VonkBart Jan Kullberg
Feb 12, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·Tilo BiedermannJosé M Carballido
Aug 2, 2015·International Journal of Biological Macromolecules·Ejaj AhmadMohammed Saleemuddin
May 27, 2005·British Journal of Haematology·Charalampos Antachopoulos, Emmanuel Roilides

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.